News | March 06, 2023
Neogen Chemicals to acquire 100% stake in BuLi Chemicals India from Livent
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
Rocuronium Bromide Injection is a neuromuscular blocking agent
The WHO - Global Center for Traditional Medicine will help member countries in taking enabling steps in their countries for strengthen education and practices of traditional mdicine
With digitally available health records, individuals can avail paper-less health services under Ayushman Bharat Digital Mission (ABDM)
Sonowal exhorted young researchers and scientist to work on evidence based scientific research
The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.
Receives regulatory approval for its molecule ‘Selumetinib’ in India
Amala Hospital partners with LifeSigns to provide revolutionary technology for the first time in the State
The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
Subscribe To Our Newsletter & Stay Updated
